159 related articles for article (PubMed ID: 20462721)
1. Forced degradation of fentanyl: identification and analysis of impurities and degradants.
Garg A; Solas DW; Takahashi LH; Cassella JV
J Pharm Biomed Anal; 2010 Nov; 53(3):325-34. PubMed ID: 20462721
[TBL] [Abstract][Full Text] [Related]
2. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
3. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n).
Thomas S; Paul SK; Shandilya S; Agarwal A; Saxena N; Awasthi AK; Matta Hb; Vir D; Mathela CS
Analyst; 2012 Aug; 137(15):3571-82. PubMed ID: 22733388
[TBL] [Abstract][Full Text] [Related]
4. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
[TBL] [Abstract][Full Text] [Related]
5. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
Rao RN; Ramakrishna K; Sravan B; Santhakumar K
J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
[TBL] [Abstract][Full Text] [Related]
6. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
[TBL] [Abstract][Full Text] [Related]
7. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
8. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
9. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
10. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
Thomas S; Bharti A; Tharpa K; Agarwal A
J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
[TBL] [Abstract][Full Text] [Related]
11. Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
Bedse G; Kumar V; Singh S
J Pharm Biomed Anal; 2009 Jan; 49(1):55-63. PubMed ID: 19022602
[TBL] [Abstract][Full Text] [Related]
12. Identification of low-level degradants from low dose tablets.
Blanchard A; Lee C; Nickerson B; Lohr LL; Jensen AJ; Alsante KM; Sharp TR; Santafianos DP; Morris R; Snyder KD
J Pharm Biomed Anal; 2004 Oct; 36(2):265-75. PubMed ID: 15496319
[TBL] [Abstract][Full Text] [Related]
13. Use of liquid chromatography/tandem mass spectrometric molecular fingerprinting for the rapid structural identification of pharmaceutical impurities.
Li M; Wang X; Chen B; Lin M; Buevich AV; Chan TM; Rustum AM
Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3533-42. PubMed ID: 19844969
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form.
Durga Rao D; Kalyanaraman L; Sait SS; Venkata Rao P
J Pharm Biomed Anal; 2010 May; 52(1):160-5. PubMed ID: 20074888
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
Kasawar GB; Farooqui M
J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
[TBL] [Abstract][Full Text] [Related]
16. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
Bansal G; Singh M; Jindal KC; Singh S
J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
[TBL] [Abstract][Full Text] [Related]
17. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
19. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
[TBL] [Abstract][Full Text] [Related]
20. A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents.
Chen Q; Zielinski D; Chen J; Koski A; Werst D; Nowak S
J Pharm Biomed Anal; 2008 Nov; 48(3):732-8. PubMed ID: 18722070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
